These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Characterizing neuropathies associated with monoclonal gammopathy of undetermined significance (MGUS): a framework consistent with classifying injuries according to fiber size. Fisher MA; Wilson JR Neurol Clin Neurophysiol; 2002; 2002(3):2-7. PubMed ID: 12028821 [TBL] [Abstract][Full Text] [Related]
6. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece. Anagnostopoulos A; Evangelopoulou A; Sotou D; Gika D; Mitsibounas D; Dimopoulos MA Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503 [TBL] [Abstract][Full Text] [Related]
7. Lower bone mineral density in geriatric patients with monoclonal gammopathy of undetermined significance. Dizdar O; Erman M; Cankurtaran M; Halil M; Ulger Z; Yavuz BB; Ariogul S; Pinar A; Harputluoglu H; Kars A; Celik I Ann Hematol; 2008 Jan; 87(1):57-60. PubMed ID: 17874101 [TBL] [Abstract][Full Text] [Related]
8. Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance. Rossi F; Petrucci MT; Guffanti A; Marcheselli L; Rossi D; Callea V; Vincenzo F; De Muro M; Baraldi A; Villani O; Musto P; Bacigalupo A; Gaidano G; Avvisati G; Goldaniga M; Depaoli L; Baldini L Clin Cancer Res; 2009 Jul; 15(13):4439-45. PubMed ID: 19509142 [TBL] [Abstract][Full Text] [Related]
14. The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance. Gregersen H; Mellemkjaer L; Ibsen JS; Dahlerup JF; Thomassen L; Sørensen HT Haematologica; 2001 Nov; 86(11):1172-9. PubMed ID: 11694403 [TBL] [Abstract][Full Text] [Related]
15. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance. Rajkumar SV; Kyle RA; Therneau TM; Clark RJ; Bradwell AR; Melton LJ; Larson DR; Plevak MF; Katzmann JA Br J Haematol; 2004 Nov; 127(3):308-10. PubMed ID: 15491291 [TBL] [Abstract][Full Text] [Related]
16. IgA monoclonal gammopathy of undetermined significance with peripheral neuropathy. Mehndiratta MM; Sen K; Tatke M; Bajaj BK J Neurol Sci; 2004 Jun; 221(1-2):99-104. PubMed ID: 15178222 [TBL] [Abstract][Full Text] [Related]
17. Peripheral neuropathies associated with monoclonal gammopathies of undetermined significance. Kelly JJ Rev Neurol Dis; 2008; 5(1):14-22. PubMed ID: 18418318 [TBL] [Abstract][Full Text] [Related]
18. [Polyneuropathy and monoclonal IgG/IgA gammopathy--differential neurography on the basis of two patient cases]. Abler B; Gdynia HJ; von Arnim CA Fortschr Neurol Psychiatr; 2009 Feb; 77(2):105-9. PubMed ID: 19221974 [TBL] [Abstract][Full Text] [Related]
19. Fracture risk in patients with monoclonal gammopathy of undetermined significance. Gregersen H; Jensen P; Gislum M; Jørgensen B; Sørensen HT; Nørgaard M Br J Haematol; 2006 Oct; 135(1):62-7. PubMed ID: 16925792 [TBL] [Abstract][Full Text] [Related]
20. [Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital]. Uchida M; Taida N; Kanao M; Kagamihara H; Kuwajima M Rinsho Byori; 2004 Jul; 52(7):574-9. PubMed ID: 15344556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]